Erytech raises $125M, lists on NASDAQ

On Nov. 10, Erytech Pharma S.A. (Euronext:ERYP; NASDAQ:ERYP) raised $125 million in a follow-on on NASDAQ and concurrent private placement. The company raised $109 million through the sale of 4.7 million ADSs at $23.26 in its initial listing on NASDAQ underwritten by Jefferies, Cowen, Oddo BHF and JMP Securities. Concurrently, the company raised €13.8 million ($16 million) through the sale of 687,327 shares at €20 in a private placement. The private placement was priced at a 17% discount to Erytech’s close of €24.19 on Oct. 6, when the offering was proposed after market hours (see BioCentury Extra, Oct. 13).

Last month, Erytech resubmitted an MAA to EMA for Graspa eryaspase to treat relapsed or refractory acute lymphoblastic leukemia (ALL). The company withdrew an MAA for the product in November 2016...